Context Therapeutics Reports First Quarter 2024 Operating and Financial Results

Go back to Context Therapeutics Reports First Quarter 2024 Operating and Financial Results
(NASDAQ: CNTX) Delayed: 0.50 +0.03 (6.38%)
Previous Close $0.47    52 Week High
Open $0.47    52 Week Low
Day High $0.51    P/E N/A 
Day Low $0.47    EPS
Volume 1,239,879